FRIOX
Price
$12.24
Change
-$0.00 (-0.00%)
Updated
Jun 10 closing price
Net Assets
4.08B
FRIQX
Price
$12.48
Change
-$0.01 (-0.08%)
Updated
Jun 10 closing price
Net Assets
4.08B
Interact to see
Advertisement

FRIOX vs FRIQX

Header iconFRIOX vs FRIQX Comparison
Open Charts FRIOX vs FRIQXBanner chart's image
FRIOX vs FRIQX Comparison Chart in %
View a ticker or compare two or three
VS
FRIOX vs. FRIQX commentary
Jun 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FRIOX is a Buy and FRIQX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FRIOX (4.08B) and FRIQX (4.08B) have equal amount of cash in the bank . FRIQX pays higher dividends than FRIOX: FRIQX (4.27) vs FRIOX (3.58). FRIOX was incepted earlier than FRIQX: FRIOX (16 years) vs FRIQX (16 years). FRIOX (1.70) is less costly to investors than FRIQX (0.95). FRIOX (24.00) and FRIQX (24.00) have comparable annual turnover. FRIOX (0) and FRIQX (0) have matching initial minimum investment requirements. FRIQX annual gain was more profitable for investors over the last year : 7.93 vs. FRIOX (7.15). FRIQX return over 5 years is better than : 14.34 vs. FRIOX (10.15).
FRIOXFRIQXFRIOX / FRIQX
Total Expense Ratio1.700.95179%
Annual Report Gross Expense Ratio1.700.95179%
Fund Existence16 years16 years-
Gain YTD3.6403.92893%
Front LoadN/A4%-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets4.08B4.08B100%
Annual Yield % from dividends3.584.2784%
Returns for 1 year7.157.9390%
Returns for 3 years24.1726.9090%
Returns for 5 years10.1514.3471%
Returns for 10 years45.3356.3480%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRDF1.600.12
+8.11%
Cardiff Oncology
NXGL0.610.04
+7.76%
NexGel
RLAY14.240.75
+5.56%
Relay Therapeutics
PKX61.152.42
+4.12%
POSCO Holdings
CEPF10.350.03
+0.29%
Cantor Equity Partners IV Inc.